Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19

Back

ESC Professional Premium Access

Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19

Session: HOT LINE 9

Topic: Pharmacotherapy

Speaker: Doctor M. Kosiborod (Kansas City, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

55 presentations

9 followers

8 more presentations in this session

RIGHT: Prolongation of anticoagulation after Primary PCI

Speaker: Associate Professor Y. Yan (Beijing, CN)

Discussant review - RIGHT

Speaker: Professor P. Vranckx (Hasselt, BE)

Access

Slides

Video

Panel discussion - RIGHT

Access

ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study

Speaker: Doctor Y. Yamashita (Kyoto, JP)

Discussant review - ONCO DVT

Speaker: Doctor T. Lopez Fernandez (Madrid, ES)

Access

Slides

Video

Access the full session

HOT LINE 9

Speakers: Doctor M. Kosiborod, Associate Professor Y. Yan, Professor P. Vranckx, Doctor Y. Yamashita, Doctor T. Lopez Fernandez

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources